title: Comment on 'A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis'.
authors.affiliation: Division of Dermatology, University of Ottawa, Ottawa Hospital, Ontario, Canada. Electronic address: maxwell.sauder@medportal.ca.
authors.forename: Maxwell B
authors.initials: MB
authors.lastname: Sauder
authors.affiliation: Division of Dermatology, University of Ottawa, Ottawa Hospital, Ontario, Canada.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Beecker
authors.affiliation: Ottawa Hospital Research Institute and Department of Epidemiology and Community Medicine, University of Ottawa, Ontario, Canada.
authors.forename: Timothy
authors.initials: T
authors.lastname: Ramsay
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D012507:Sarcoidosis / Q000188:drug therapy*; D012871:Skin Diseases / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized